ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 87 locations in 38 countries and has approximately 12,300 employees. Further information is available at www.iconplc.com.
Session Spotlight Sponsor
Certara is a global biosimulation and regulatory writing company, committed to optimizing drug development decisions. Its clients include hundreds of international biopharmaceutical companies, leading academic institutions, and key regulatory agencies. Certara’s solutions, which span drug discovery through patient care, increase the probability of regulatory and commercial success by using the most scientifically-advanced modeling and simulation technologies and regulatory strategies.
InClinica is a global clinical contract research organisation. Our capabilities span the breadth of clinical research, with an emphasis on early phase clinical development.
Our key therapeutic areas include oncology, metabolic diseases, cardiovascular diseases, inflammatory diseases, and infectious diseases.
Services offered include, on-site monitoring, site initiation, routine monitoring, close-out visits, protocol development, and post-market surveillance. We are also experienced in managing: global study budgets, external and third party vendors, central laboratory services, data management, and other relevant clinical trial activities.
InClinica is headquartered in Philadelphia – U.S.A, with global presence in Birmingham – U.K., Athens – Greece, Tel Aviv – Israel, and our Asia-Pacific headquarter in Kuala Lumpur – Malaysia.
Almac Group, headquartered in Craigavon, Northern Ireland, is an established, leading contract development and manufacturing organisation providing an extensive range of integrated services to over 600 pharmaceutical and biotech companies globally.
Its Clinical Services Business, operating in Europe, US, and Asia, offers services including drug procurement, CSM, blinding, primary & secondary packaging, storage, temperature management & distribution and QP services.
Almac Website: www.almacgroup.com
Almac Clinical Services Website: https://www.almacgroup.com/development-manufacturing/clinical-services/
Barrington James are a Global specialist recruitment consultancy with offices in Asia, USA and Europe that work across the Healthcare sector. Our structure, with separate divisions and dedicated consultants for the markets we serve ensures a thorough, professional and intelligent approach in both permanent and interim solutions. Our tailored methodologies include Contingency database search and executive search.
Lionbridge Life Sciences is the leading provider of language and globalization services for pharmaceutical companies, CROs, and medical device manufacturers. Our specialized network of medically trained linguists specialize in high-quality translation, linguistic validation, and interpretation services in 250+ languages and operate in over 40 full-service solution centers across 27 countries.
Myoderm is a global leader in sourcing, distribution, and management of commercial drugs for clinical trials and biosimilar research. Our deep expertise and our obsession with ensuring efficient and effective trials are why pharmaceutical and biotech companies, CROs, and clinical packagers around the world rely on us for their supply needs.
Headquartered in Sydney and operating across 12 countries in the Asia Pacific, Novotech is unique amongst midsize CROs servicing the region. With services developed over 20 years and hundreds of phase II/III clinical studies across a diverse range of therapeutic areas, Novotech’s local expertise makes it the ideal development partner for smaller sponsors with little or no presence in the region.